Boynton John Wilson IV has filed a Form 144 to sell 333 shares of Nebius Group N.V. This filing, dated October 29, 2026, is significant as it reflects a liquidity event for the director of the company. The sale comes amid a series of transactions under a 10b5-1 plan, which allows for scheduled sales of stock, indicating ongoing activity in the tech services sector.
Background
Nebius Group N.V. operates in the services sector, specifically focusing on computer programming and data processing. The company is incorporated in P7 and has a Central Index Key (CIK) of 0001513845. The recent filings indicate that Boynton John Wilson IV is actively managing his holdings in the company, which is crucial for transparency and regulatory compliance.
What the Filing Says
The filing states that Boynton John Wilson IV intends to sell 333 shares of common stock, acquired as restricted stock units on January 3, 2025. The aggregate market value of the shares to be sold is approximately $60,719.22. The filing also notes that the shares will be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.
Impact
This move may affect various stakeholders, including shareholders and potential investors in Nebius Group N.V. The ongoing sales under the 10b5-1 plan reflect the director's strategy to manage liquidity and could influence market perceptions of the company's stock.
What's Next
The filing does not say what happens next.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










